Skip to main content

Table 3 Subgroup analysis of LDL-C level with mortality among CAD and CKD patients

From: Association between baseline LDL-C and prognosis among patients with coronary artery disease and advanced kidney disease

Subgroup

No of events / No of patients

Multivariate Cox Regression

P for interaction

LDL-C < 1.8

LDL-C ≥ 1.8

HR

95% CI

P value

On dialysis

 Yes

39/67 (58.2%)

86/216 (39.8%)

1.66

1.03

2.68

0.04

0.38

 No

36/71 (50.7%)

154/449 (34.3%)

1.22

0.79

1.88

0.38

ACS

 Yes

31/58 (53.4%)

120/328 (36.6%)

1.36

0.84

2.19

0.21

0.76

 No

44/80 (55.0%)

120/337 (35.6%)

1.33

0.87

2.02

0.18

DM

 Yes

48/86 (55.8%)

129/343 (37.6%)

1.59

1.05

2.40

0.03

0.35

 No

27/52 (51.9%)

111/322 (34.5%)

1.30

0.78

2.18

0.32

  1. Abbreviations: ACS Acute coronary syndrome; DM Diabetes mellitus
  2. Adjusted for full multivariate variables: age, male, current smoker, ACS, CHF, hypertension, DM, dialysis, anemia, PAD, 15 ≤ eGFR < 30 ml/min/1.73 m2 vs. eGFR < 15 ml/min/1.73 m2, previous AMI, PCI, WBC, albumin, total Cholesterol, triglyceride, high-density lipoprotein cholesterol, Lg ProBNP, Lg D-dimer, ACEI/ARB, β-blockers, statins, diuretics